Skip to content
healthcare.dev

Ondansetron

NDC 72336-073, Ondansetron, tablet, orally disintegrating, from Lifsa Drugs LLC.

Product NDC
72336-073
Status
Listed
Labeler
Lifsa Drugs LLC
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077406
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72336-073 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ONDANSETRON16 mg/1

Pharmacologic classes

Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]

Package NDCNDC-11Package
72336-073-307233600733030 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (72336-073-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c66d63cf-a0e5-4cb5-bdf8-9d1115cba23e
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=72336-073

Use it

Look up 72336-073 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72336-073 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72336-073. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.